Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3α (GSK-3α): Development and impact on temozolomide treatment of glioblastoma cells

Autor: Hasyeoui, Mohamed, Lassagne, Frédéric, Erb, William, Nael, Manal, Elokely, Khaled M., Chaikuad, Apirat, Knapp, Stefan, Jorda, Adrian, Vallés, Soraya L., Quissac, Emie, Verreault, Maïté, Robert, Thomas, Bach, Stéphane, Samarat, Ali, Mongin, Florence
Zdroj: In Bioorganic Chemistry May 2023 134
Databáze: ScienceDirect